论文部分内容阅读
新生儿免疫性血小板减少性紫癜实属于先天性免疫性血小板减少性紫癜疾病。但其发病并非来自新生儿本身,乃是由于母体产生的免疫抗体传入儿体所致。发病率虽占1～2/万,是一种少见病。然而,儿科医师对本病的诊断和处理有必要熟悉和掌握。因之,本文只作概要介绍。发病机制:本病主要是由于母体内的免疫抗体传入儿体内所致,按其免疫抗体的性质,可归纳三点:1.患儿母亲原有特发性血小板减少性紫癜(ITP),故
Neonatal immune thrombocytopenic purpura actually belong to the congenital immune thrombocytopenic purpura disease. But its incidence does not come from the newborn itself, but because of maternal immune antibodies introduced into the body due. Although the incidence of 1 to 2 / million, is a rare disease. However, pediatricians need to be familiar with and master the diagnosis and treatment of this disease. Therefore, this article only for summary introduction. Pathogenesis: The disease is mainly due to maternal immune antibodies introduced into the body caused by the body, according to the nature of its immune antibodies, can be summarized in three points: 1. The original mother of the children with idiopathic thrombocytopenic purpura (ITP) Therefore